重點成果

重點成果

• 
  2021-11-23 重點成果

  Novel monodisperse FePt nanocomposites for T2-weighted magnetic resonance imaging: biomedical theranostics applications

  蕭宏昇
  Nanoscale Advances

• 
  2021-10-15 重點成果

  Immunogenicity evaluation of N-glycans recognized by HIV broadly neutralizing antibodies

  翁啟惠
  ACS Chemical Biology

• 
  2021-10-09 重點成果

  Magnetically Guided Theranostics: Montmorillonite-Based Iron/Platinum Nanoparticles for Enhancing in Situ MRI Contrast and Hepatocellular Carcinoma Treatment

  蕭宏昇
  Journal of Nanobiotechnology

• 
  2021-08-20 重點成果

  Combined effect of anti-SSEA4 and anti-Globo H antibodies on breast cancer cells

  翁啟惠
  ACS Chemical Biology

• 
  2021-08-05 重點成果

  A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells

  林國儀
  PLoS Pathogens

• 
  2021-07-13 重點成果

  Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function

  黃雯華
  Scientific Reports

• 
  2021-06-01 重點成果

  SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection

  謝世良
  The Journal of Clinical Investigation

• 
  2021-05-25 重點成果

  Activation of Prp28 ATPase by Phosphorylated Npl3 at a Critical Step of Spliceosome Remodeling

  張典顯
  Nature Communications

• 
  2021-05-10 重點成果

  Marginal Zone B Cells Assist With Neutrophil Accumulation to Fight Against Systemic Staphylococcus aureus Infection

  林國儀
  FRONTIERS IN IMMUNOLOGY

• 
  2021-04-14 重點成果

  HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma

  楊懷壹
  The Journal of Infectious Diseases